MUMBAI, India, July 24 -- Intellectual Property India has published a patent application (202647084910 A) filed by Ares Trading S. A. on July 10, 2026, for Cladribine Regimen For Treating Myasthenia Gravis.
Inventors include Becker, Andreas Werner; Ravula, Abhigyan; Goteti, Kosalaram; Alexandri, Nektaria; Boschert Shafaatian, Ursula; Koehl, Niklas Julian Number; Von Burkersroda, Friederike; Wiedey, Raphael; Assi, Pardis; and Jung, Markus.
The application for the patent was published on July 17, 2026, under issue no. 29/2026.
Abstract: The present invention relates to compounds for the treatment of Myasthenia Gravis and related methods and dosing regimen. Specifically, the invention pertains to the field of treatment scheme of oral formulation of cladribine and relevant for the treatment of Myasthenia Gravis, more specifically generalized Myasthenia Gravis.
Disclaimer: Curated by HT Syndication.
